THURSDAY, Dec. 6, 2018 (HealthDay News) — It’s not standard practice in the United States, but supervised access to medical-grade heroin may reduce the risk of harm for heroin addicts unable to kick the habit, new research suggests. This approach has been successful in other countries and should be triedContinue Reading
THURSDAY, Nov. 29, 2018 (HealthDay News) — Methamphetamine and opioid use has soared among pregnant American women, putting the health of baby and mother at risk, a new study finds. While addiction among pregnant women has dramatically increased across the country, it disproportionally affects women living in rural America, whereContinue Reading
TUESDAY, Nov. 20, 2018 (HealthDay News) — As the U.S. opioid epidemic rages unchecked, new research shows that pregnancy-related deaths due to opioid misuse more than doubled between 2007 and 2016. Deaths during or soon after pregnancy rose 34 percent during that time, and the percentage involving heroin, fentanyl orContinue Reading
TUESDAY, May 1, 2018 (HealthDay News) — People suffering from post-traumatic stress disorder (PTSD) might find some relief by using the popular party drug ecstasy, a small study suggests. Technically, this synthetic drug is called 3,4-methylenedioxy-methamphetamine (MDMA) and it alters mood and perception. When tried with 26 veterans and firstContinue Reading
TUESDAY, Feb. 20, 2018 (HealthDay News) — Researchers say they are one step closer to testing a heroin vaccine in humans — in what they hope will become an additional weapon in fighting America’s opioid epidemic. Scientists at The Scripps Research Institute, in California, have developed an experimental vaccine thatContinue Reading
FRIDAY, Dec. 1, 2017 (HealthDay News) — A once-monthly injection of the opioid addiction drug buprenorphine has been approved by the U.S. Food and Drug Administration. “Millions of Americans are suffering from addiction to opioid drugs, and millions more are worried that the overdose epidemic could claim the lives ofContinue Reading
WEDNESDAY, Nov. 15, 2017 (HealthDay News) — The top two medications used to treat opioid addiction appear equally safe and effective, a new study finds. With the United States in the midst of an unprecedented opioid crisis, researchers conducted a head-to-head trial of two leading addiction treatments — naltrexone (Vivitrol)Continue Reading
Rate plateaus as doctors are urged to recommend nondrug pain treatmentsContinue Reading
‘It only takes a little to lose a lot’ is slogan for the multi-pronged media effortContinue Reading
Most of these strokes involve bleeding into the brain: studyContinue Reading
And heroin led to the most deaths among 15- to 19-year-olds, CDC saysContinue Reading
U.S. cases rose 75 percent for females vs. 55 percent for males over a decade, study findsContinue Reading
Pills women don’t use may end up in the wrong hands, researchers suggestContinue Reading
Researchers hope it will prove as effective in human tests and become an aid for recovering addictsContinue Reading